Advanced search
Publication Cover
Leukemia & Lymphoma Volume 38, 2000 - Issue 3-4
Submit an article Journal homepage
91
Views
45
CrossRef citations to date
0
Altmetric
Original Article

Predictive Factors for Central Nervous System Involvement in Non-Hodgkin's Lymphoma: Significance of Very High Serum LDH Concentrations

Naoto Tomita Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Fumio Kodama Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Rika Sakai Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Hideyuki Koharasawa Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Michiko Hattori Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Jun Taguchi Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Hiroyuki Fujita Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Juichi Tanabe Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Shin Fujisawa Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Hitoshi Fukawa Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Hiroshi Harano Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Heiwa Kanamori Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Hiroko Miyashita Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Michio Matsuzaki Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Koji Ogawa Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Sigeki Motomura Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
,
Atsuo Maruta Department of Hematology and Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan
&
Yoshiaki Ishigatsubo First Department of Internal Medicine, Yokohama City University School of Medicine, Yokohama, Japan
 show all
Pages 335-343 | Received 30 Oct 1999, Published online: 01 Jul 2009

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Yi-Zhen Liu, Pan Luo, Cheng Liu, Kai Xue, Jia Jin, Zu-Guang Xia, Xiao-Jian Liu, Qun-Ling Zhang, Jun-Ning Cao, Xiao-Nan Hong & Fang-Fang Lv. (2019) Prognostic Significance of LDH Ratio in Serum/Cerebral Spinal Fluid of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma. OncoTargets and Therapy 12, pages 10469-10475.
Read now
Danish Mazhar, Justin Stebbing & Mark Bower. (2006) Non-Hodgkin’s lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals. Expert Review of Anticancer Therapy 6:3, pages 335-341.
Read now
Sakher Abdullah, Daniel Morgensztern, Manuel F. Rosado & Izidore S. Lossos. (2005) Primary lymphoblastic B-cell lymphoma of the cranial dura mater: a case report and review of the literature. Leukemia & Lymphoma 46:11, pages 1651-1657.
Read now
S.L. Chua, J.F. Seymour, J. Streater, M.M. Wolf, E.H. Januszewicz & H.M. Prince. (2002) Intrathecal Chemotherapy alone is Inadequate Central Nervous System Prophylaxis in Patients with Intermediate-grade Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 43:9, pages 1783-1788.
Read now

Articles from other publishers (41)

Daniela A. Pimentel MaldonadoRobert LisakSteven GalettaLaura BalcerThomas VarkeyAndrew GoodmanJennifer GravesMichael RackeScott S. ZamvilScott NewsomeElliot M. FrohmanTeresa C. Frohman. (2023) Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery. Neurology Neuroimmunology & Neuroinflammation 10:1.
Crossref
Laura Faiver, Olivia Gutgsell & Yoshie Umemura. 2023. Cerebrospinal Fluid and Subarachnoid Space. Cerebrospinal Fluid and Subarachnoid Space 31 46 .
Tiantian Sun, Mi Zhou & Liang Huang. (2022) Chimeric antigen receptor engineered T-cell therapy for central nervous system lymphoma. Hematology and Oncology Discovery 1:1.
Crossref
Yunchao Ban, Zhitao Jing & Jingyu Zou. (2019) Multiple secondary cauda equina non-Hodgkin’s lymphoma: a case report and literature review. BMC Cancer 19:1.
Crossref
Yuchen Wu, Yaming Wang, Xuefei Sun, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Ruixian Xing, Yuedan Chen, Qing Liu, Jiayuan Guo, Nan Ji, Shengjun Sun & Yuanbo Liu. (2019) Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population. BMC Neurology 19:1.
Crossref
Lon V Kendall, James R Owiny, Erik D Dohm, Katie J Knapek, Erin S Lee, Jennifer H Kopanke, Michael Fink, Sarah A Hansen & Jessica D Ayers. (2018) Replacement, Refinement, and Reduction in Animal Studies With Biohazardous Agents. ILAR Journal 59:2, pages 177-194.
Crossref
Jennifer H. Kopanke, Annie V. Chen, Jourdan E. Brune, Amanda C. Brenna & Stephanie A. Thomovsky. (2018) Reference intervals for the activity of lactate dehydrogenase and its isoenzymes in the serum and cerebrospinal fluid of healthy canines. Veterinary Clinical Pathology 47:2, pages 267-274.
Crossref
Dariusz Szczepanek, Ewa Wąsik-Szczepanek, Agnieszka Szymczyk, Małgorzata Wach, Maria Cioch, Monika Podhorecka, Ewelina Grywalska & Marek Hus. (2018) Central nervous involvement by chronic lymphocytic leukaemia. Neurologia i Neurochirurgia Polska 52:2, pages 228-234.
Crossref
Elizabeth S. Duke, Scott L. Pomeroy & Nicole J. Ullrich. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice 597 614 .
Lee Cheng, Alma Y. DeJesus & Maria A. Rodriguez. (2017) Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer. Journal of Pain and Symptom Management 53:4, pages 720-727.
Crossref
Seok Jin Kim, Jun Sik Hong, Myung Hee Chang, Jeong-A Kim, Jae-Yong Kwak, Jin Seok Kim, Dok Hyun Yoon, Won Sik Lee, Young Rok Do, Hye Jin Kang, Hyeon-Seok Eom, Yong Park, Jong-Ho Won, Yeung-Chul Mun, Hyo Jung Kim, Jung Hye Kwon, Jee Hyun Kong, Sung Yong Oh, Sunah Lee, Sung Hwa Bae, Deok-Hwan Yang, Hyun Jung Jun, Yang Soo Kim, Hwan Jung Yun, Soon Il Lee, Min Kyoung Kim, Eun Kyung Park, Won Seog Kim & Cheolwon Suh. (2016) Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study. Oncotarget 7:44, pages 72033-72043.
Crossref
Megan M. Herr, Nimish A. Mohile, Paul M. Barr, Edwin van Wijngaarden, Edward B. Brown & David Q. Rich. (2016) Survival of Secondary Central Nervous System Lymphoma Patients in the Rituximab Era. Clinical Lymphoma Myeloma and Leukemia 16:9, pages e123-e127.
Crossref
Ewa Wąsik-Szczepanek, Dariusz Szczepanek, Małgorzata Wach & Marek Hus. (2016) Zmiany białaczkowe w ośrodkowym układzie nerwowym w przebiegu przewlekłej białaczki limfocytowej. Acta Haematologica Polonica 47:1, pages 10-14.
Crossref
Jennifer C. Houle, Annie V. Chen, Amanda C. Brenna, Katrina L. Mealey & Alecia M. Kiszonas. (2015) Determination of optimal storage temperature and duration for analysis of total and isoenzyme lactate dehydrogenase activities in canine serum and cerebrospinal fluid. Veterinary Clinical Pathology 44:2, pages 253-261.
Crossref
Abhimanyu Ghose, Ria Kundu & Tahir Latif. (2014) Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma. Critical Reviews in Oncology/Hematology 91:3, pages 292-303.
Crossref
Nuri Karadurmus, Selmin Ataergin, Gokhan Erdem, Mustafa Cakar, Ozdes Emer, Sukru Ozaydin, Mustafa Ozturk, Mukerrem Safali & Fikret Arpaci. (2013) A Rare Presentation of Follicular Lymphoma: Cerebellar Involvement, Successfully Treated with a Combination of Radiotherapy and Chemotherapy. Cancer Research and Treatment 45:3, pages 234-238.
Crossref
Tali Siegal & Neta Goldschmidt. (2012) CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?. Blood Reviews 26:3, pages 97-106.
Crossref
Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Yasufumi Masaki, Saburo Tsunoda, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Ohshima, Yoshihiro Hatta, Yukiyoshi Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Yoshiaki Ishigatsubo & Kengo Takeuchi. (2012) Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Science 103:2, pages 245-251.
Crossref
Mustafa Khasraw, Ariela Noy, Mark Gilbert & Antonio Omuro. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System 267 285 .
Juan-Manuel Sancho, Alberto Orfao, Sandra Quijano, Olga García, Carlos Panizo, Elena Pérez-Ceballos, Guillermo Deben, Antonio Salar, Eva González-Barca, Natalia Alonso, Jose-Antonio García-Vela, Javier Capote, Francisco-Javier Peñalver, Mariano Provencio, Jesús Arias, Josefa Plaza, Dolores Caballero, Marta Morado, Evarist Feliu & Josep-Maria Ribera. (2010) Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin’s lymphoma patients at high risk of central nervous system disease in the rituximab era. European Journal of Haematology 85:4, pages 321-328.
Crossref
Wataru Yamamoto, Naoto Tomita, Reina Watanabe, Yukako Hattori, Yuki Nakajima, Rie Hyo, Chizuko Hashimoto, Shigeki Motomura & Yoshiaki Ishigatsubo. (2010) Central nervous system involvement in diffuse large B‐cell lymphoma. European Journal of Haematology 85:1, pages 6-10.
Crossref
Laura Marconato, Giampaolo Crispino, Riccardo Finotello, Silvia Mazzotti & Eric Zini. (2010) Clinical relevance of serial determinations of lactate dehydrogenase activity used to predict recurrence in dogs with lymphoma. Journal of the American Veterinary Medical Association 236:9, pages 969-974.
Crossref
D. Villa, J.M. Connors, T.N. Shenkier, R.D. Gascoyne, L.H. Sehn & K.J. Savage. (2010) Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Annals of Oncology 21:5, pages 1046-1052.
Crossref
Jennifer A. Smith & Michael Glantz. (2009) Statistical and Trial Design Considerations in Central Nervous System Prophylaxis Studies. Seminars in Oncology 36, pages S69-S76.
Crossref
Ulrich Herrlinger, Michael Glantz, Uwe Schlegel, Christian Gisselbrecht & Franco Cavalli. (2009) Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More. Seminars in Oncology 36, pages S25-S34.
Crossref
Ching-Hon Pui & Eckhard Thiel. (2009) Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical Applications. Seminars in Oncology 36, pages S2-S16.
Crossref
Juan-Manuel Sancho, Mireia Morgades, Natalia Alonso, Guillermo Deben, Alberto Fernández de Sevilla, Lourdes Vázquez, Concepción Nicolás, José-Antonio García Vela, Reyes Arranz, Eugenia Abella, Miguel-Ángel Canales, Pilar Miralles, Eva Sánchez, Mar Hermosilla, Eulogio Conde, Antonio Rueda & Josep-Maria Ribera. (2008) Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin’s lymphoma in Spain. Medicina Clínica 131:12, pages 441-446.
Crossref
Hwee Yong Lim, Eckhard Thiel & Michael J Glantz. (2008) To protect and defend: central nervous system prophylaxis in patients with non-Hodgkinʼs lymphoma. Current Opinion in Oncology 20:5, pages 495-501.
Crossref
Nicole J. Ullrich & Scott L. Pomeroy. 2008. Cancer Neurology In Clinical Practice. Cancer Neurology In Clinical Practice 607 619 .
Sang-Yeon Suh & Hong-Yup Ahn. (2007) Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: A preliminary study. European Journal of Cancer 43:6, pages 1051-1059.
Crossref
H.-T. Arkenau, G. Chong, D. Cunningham, D. Watkins, R. Agarwal, B. Sirohi, M. Trumper, A. Norman, A. Wotherspoon & A. Horwich. (2007) The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Annals of Oncology 18:3, pages 541-545.
Crossref
Quentin A. Hill & Roger G. Owen. (2006) CNS prophylaxis in lymphoma: Who to target and what therapy to use. Blood Reviews 20:6, pages 319-332.
Crossref
N.L. Grupka, J. Seinfeld, J. Ryder, K.O. Lillehei & B.K. Kleinschmidt-DeMasters. (2006) Secondary central nervous system involvement by follicular lymphoma: case report and review of the literature. Surgical Neurology 65:6, pages 590-594.
Crossref
C. W. Cheung, C. Burton, P. Smith, D. C. Linch, P. J. Hoskin & K. M. Ardeshna. (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. British Journal of Haematology 131:2, pages 193-200.
Crossref
Philip Bierman & Pierre Giglio. (2005) Diagnosis and Treatment of Central Nervous System Involvement in Non-Hodgkin's Lymphoma. Hematology/Oncology Clinics of North America 19:4, pages 597-609.
Crossref
G. Spectre, A. Gural, G. Amir, A. Lossos, T. Siegal & O. Paltiel. (2005) Central nervous system involvement in indolent lymphomas. Annals of Oncology 16:3, pages 450-454.
Crossref
Martin Begemann, Martin Schabet & Lisa M. DeAngelis. 2003. Neurological Disorders. Neurological Disorders 865 879 .
Naoto Tomita, Fumio Kodama, Heiwa Kanamori, Shigeki Motomura & Yoshiaki Ishigatsubo. (2002) Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non‐hodgkin lymphoma. Cancer 95:3, pages 576-580.
Crossref
A. Hollender, S. Kvaloy, O. Nome, E. Skovlund, K. Lote & H. Holte. (2002) Central nervous system involvement following diagnosis ofnon-Hodgkin’s lymphoma: a risk model. Annals of Oncology 13:7, pages 1099-1107.
Crossref
J. Wellwood & K. Taylor. (2002) Central nervous system prophylaxis in haematological malignancies. Internal Medicine Journal 32:5-6, pages 252-258.
Crossref
Bertrand Coiffier. (2001) Diffuse large cell lymphoma. Current Opinion in Oncology 13:5, pages 325-334.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.